Regina G. S.
- Country
- Spain
- Department
- N/A
Research Overview
- ONC201 for the Treatment of Newly Diagnosed H3 K27M-mutant Diffuse Glioma Following Completion of Radiotherapy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study (The ACTION Study)
- Long-Term Safety Evaluation of Lutetium (177Lu) Vipivotide Tetraxetan in Adult Prostate Cancer Patients: A Phase IV Post-Authorization Study
- Phase III Study of Savolitinib Plus Durvalumab Versus Sunitinib and Durvalumab Monotherapy in MET-Driven Unresectable or Metastatic Papillary Renal Cell Carcinoma
Data & Insights
Has run more than one trial at 164 of 340 partner sites.
Specializations
Urological Oncology
Specializes in advancing treatment approaches for metastatic prostate cancer, including both hormone-sensitive and castration-resistant variants. The investigator conducts research into novel therapeutic combinations involving immunotherapy and targeted treatments for bladder cancer, particularly focusing on high-risk non-muscle invasive cases.
- Prostate Cancer Therapeutics
- Bladder Cancer Management
- PSMA-Targeted Therapies
Neuro-Oncology
Focuses on innovative treatments for glioblastoma and other brain cancers, investigating new therapeutic approaches including tumor-treating fields and novel drug combinations. The research encompasses both newly diagnosed and recurrent cases of brain tumors, with particular attention to molecular targeted therapies.
- Glioblastoma Treatment
- Brain Cancer Therapeutics
- Diffuse Glioma Management
Kidney Cancer
Investigates advanced treatments for renal cell carcinoma, including both clear cell and non-clear cell variants. The research focus includes combinations of immune checkpoint inhibitors with targeted therapies, particularly in the context of metastatic disease.
- Advanced Renal Cell Carcinoma
- Immunotherapy Combinations
- Targeted Therapeutic Approaches
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.